Vaccine Design and Testing – Products

Thermo Fisher’s new 1500 Series BSC boosts lab safety, ergonomic comfort and workflow with real-time airflow tech.

Aptamer licenses Optimers to the University of Glasgow for use in swine vaccines, targeting global animal health markets.

Thermo Fisher Scientific and the Chan Zuckerberg Imaging Institute have announced a partnership to develop new technologies that enhance cryo-electron microscopy (cryo-EM).

On February 28, 2025, WHO announced the recommended strains for the 2025-2026 northern hemisphere influenza season.

Thermo Fisher Scientific introduces the Thermo Scientific™ TSX™ Core Series ULT freezers, designed to provide reliable performance and robust durability in a user-friendly solution.

On February 18, 2025, Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a twice-yearly injectable HIV-1 capsid inhibitor for pre-exposure prophylaxis (PrEP).

This whitepaper explores how peptones are revolutionizing vaccine development, offering a path to enhanced performance without the dependence on a fluctuating serum supply chain.

DNA Script announced a significant advancement in oligonucleotide synthesis technology, enabling the production of custom DNA sequences of up to 500 nucleotides in length with unprecedented sequence complexity.

ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative anticancer virus platform, the SJ-600 series.

ACROBiosystems offers premium antigens (pre-fusion F, post-fusion F, glycoprotein G) and a Monoclonal Anti-Nipah Antibody for accurate ELISA-based evaluation and vaccine potency studies, supporting Nipah and Hendra virus research.